CH569732A5 - - Google Patents

Info

Publication number
CH569732A5
CH569732A5 CH450174A CH450174A CH569732A5 CH 569732 A5 CH569732 A5 CH 569732A5 CH 450174 A CH450174 A CH 450174A CH 450174 A CH450174 A CH 450174A CH 569732 A5 CH569732 A5 CH 569732A5
Authority
CH
Switzerland
Application number
CH450174A
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CH569732A5 publication Critical patent/CH569732A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH450174A 1970-06-05 1971-06-02 CH569732A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702027645 DE2027645A1 (de) 1970-06-05 1970-06-05 Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH569732A5 true CH569732A5 (enExample) 1975-11-28

Family

ID=5773104

Family Applications (3)

Application Number Title Priority Date Filing Date
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.
CH450174A CH569732A5 (enExample) 1970-06-05 1971-06-02

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.

Country Status (10)

Country Link
US (1) US3984555A (enExample)
AT (3) AT318628B (enExample)
BE (1) BE768137A (enExample)
CA (1) CA951319A (enExample)
CH (3) CH558374A (enExample)
DE (1) DE2027645A1 (enExample)
FR (1) FR2100726B1 (enExample)
GB (1) GB1331522A (enExample)
LU (1) LU63267A1 (enExample)
NL (1) NL7107695A (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US6723727B1 (en) * 1996-12-20 2004-04-20 Hoechst Aktiengesellschaft Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
US5972929A (en) * 1997-08-21 1999-10-26 Shiseido Co., Ltd. Quinazolinone derivative, hair growth promoter and external composition for skin using the same
EP1216243A1 (en) 1999-10-01 2002-06-26 Advanced Medicine, Inc. Quinazolinones and analogues and their use as local anesthetics
MXPA02010618A (es) * 2000-04-25 2004-05-05 Icos Corp Inhibidores de fosfatidilinositol 3-quinasa delta.
US6667300B2 (en) * 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
ATE469648T1 (de) 2001-09-05 2010-06-15 Minerva Biotechnologies Corp Zusammensetzungen und deren verwendung zur behandlung von krebs
US20030119834A1 (en) * 2001-09-05 2003-06-26 Bamdad Cynthia C. Compositions and methods of treatment of cancer
EP1444209A4 (en) * 2001-11-07 2005-02-16 Merck & Co Inc INHIBITORS OF MITOTIC KINESINS
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
AU2003262747A1 (en) * 2002-08-21 2004-03-11 Cytokinetics, Inc. Compounds, compositions, and methods
AU2003291761A1 (en) * 2002-11-04 2004-06-07 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
EP1646615B1 (en) * 2003-06-06 2009-08-26 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives as modulators of atp-binding cassette transporters
WO2005016348A1 (en) * 2003-08-14 2005-02-24 Icos Corporation Method of inhibiting immune responses stimulated by an endogenous factor
WO2005016349A1 (en) * 2003-08-14 2005-02-24 Icos Corporation Methods of inhibiting leukocyte accumulation
PL1761540T3 (pl) 2004-05-13 2017-06-30 Icos Corporation Chinazolinony jako inhibitory ludzkiej kinazy 3-fosfatydyloinozytolu delta
JP2008500338A (ja) * 2004-05-25 2008-01-10 イコス・コーポレイション 造血細胞の異常増殖を治療及び/又は予防する方法
EP1885356A2 (en) * 2005-02-17 2008-02-13 Icos Corporation Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
EP2233472B1 (en) * 2006-03-28 2014-01-15 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
NZ631024A (en) 2008-11-13 2016-04-29 Gilead Calistoga Llc Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
SG174529A1 (en) 2009-03-24 2011-10-28 Gilead Calistoga Llc Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
PT2421536E (pt) * 2009-04-20 2015-10-20 Gilead Calistoga Llc Métodos de tratamento para tumores sólidos
EP2456443A1 (en) 2009-07-21 2012-05-30 Gilead Calistoga LLC Treatment of liver disorders with pi3k inhibitors
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
WO2012140642A1 (en) 2011-04-10 2012-10-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
AP2014007875A0 (en) 2012-03-05 2014-08-31 Gilead Calistoga Llc Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
IN2015MN00002A (enExample) 2012-07-09 2015-10-16 Lupin Ltd
PT3083630T (pt) 2013-12-20 2019-11-15 Gilead Calistoga Llc Procedimentos para inibidores da fosfatidilinositol 3-quinase
EP3083623A1 (en) 2013-12-20 2016-10-26 Gilead Calistoga LLC Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
JP6455995B2 (ja) 2014-06-13 2019-01-23 ギリアード サイエンシーズ, インコーポレイテッド ホスファチジルイノシトール3−キナーゼ阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053063A (enExample) * 1963-05-18

Also Published As

Publication number Publication date
CH558374A (de) 1975-01-31
NL7107695A (enExample) 1971-12-07
CA951319A (en) 1974-07-16
BE768137A (fr) 1971-12-06
FR2100726A1 (enExample) 1972-03-24
AT318615B (de) 1974-11-11
LU63267A1 (enExample) 1972-08-23
AT318628B (de) 1974-11-11
GB1331522A (en) 1973-09-26
AT317899B (de) 1974-09-25
FR2100726B1 (enExample) 1975-10-10
US3984555A (en) 1976-10-05
CH557829A (de) 1975-01-15
DE2027645A1 (de) 1971-12-09

Similar Documents

Publication Publication Date Title
FR2100726B1 (enExample)
FR2221062A1 (enExample)
FR2111638B1 (enExample)
JPS47199U (enExample)
FR2111897A1 (enExample)
FR2112006B1 (enExample)
FR2111454A5 (enExample)
JPS47197U (enExample)
FR2110730A7 (enExample)
JPS493485B1 (enExample)
FR2111921A1 (enExample)
JPS4722850Y1 (enExample)
JPS4813152Y1 (enExample)
JPS4724268Y1 (enExample)
FR2111645B2 (enExample)
JPS471766Y1 (enExample)
JPS4722438Y1 (enExample)
JPS4721785Y1 (enExample)
JPS4721587Y1 (enExample)
JPS4721469Y1 (enExample)
JPS4725246Y1 (enExample)
JPS4812407Y1 (enExample)
JPS4812646B1 (enExample)
JPS4713319Y1 (enExample)
JPS4813117Y1 (enExample)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased